Long-term impact of COVID-19-related nonpharmaceutical interventions on tuberculosis: an interrupted time series analysis using Bayesian method
- PMID: 39849949
- PMCID: PMC11758172
- DOI: 10.7189/jogh.15.04012
Long-term impact of COVID-19-related nonpharmaceutical interventions on tuberculosis: an interrupted time series analysis using Bayesian method
Abstract
Background: The implementation of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic may inadvertently influence the epidemiology of tuberculosis (TB). (TB). However, few studies have explored how NPIs impact the long-term epidemiological trends of TB. We aimed to estimate the impact of NPIs implemented against COVID-19 on the medium- and long-term TB epidemics and to forecast the epidemiological trend of TB in Henan.
Methods: We first collected monthly TB case data from January 2013 to September 2022, after which we used the data from January 2013 to December 2021 as a training data set to fit the Bayesian structural time series (BSTS) model and the remaining data as a testing data set to validate the model's predictive accuracy. We then conducted an intervention analysis using the BSTS model to evaluate the impact of the COVID-19 pandemic on TB epidemics and to project trends for the upcoming years.
Results: A total of 590 455 TB cases were notified from January 2013 to September 2022, resulting in an annual incidence rate of 57.4 cases per 100 000 population, with a monthly average of 5047 cases (5.35 cases per 100 000 population). The trend in TB incidence showed a significant decrease during the study period, with an annual average percentage change of -7.3% (95% confidence interval (CI) = -8.4, -6.1). The BSTS model indicated an average monthly reduction of 25% (95% CI = 17, 32) in TB case notifications from January 2020 to December 2021 due to COVID-19 (probability of causal effect = 99.80%, P = 0.002). The mean absolute percentage error in the forecast set was 14.86%, indicating relatively high predictive accuracy of the model. Furthermore, TB cases were projected to total 43 584 (95% CI = 29 471, 57 291) from October 2022 to December 2023, indicating a continued downward trend.
Conclusions: COVID-19 has had medium- and long-term impacts on TB epidemics, while the overall trend of TB incidence in Henan is generally declining. The BSTS model can be an effective option for accurately predicting the epidemic patterns of TB, and its results can provide valuable technical support for the development of prevention and control strategies.
Copyright © 2025 by the Journal of Global Health. All rights reserved.
Conflict of interest statement
Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and disclose no relevant interests.
Figures




Similar articles
-
Evaluation of the impact of COVID-19 on hepatitis B in Henan Province and its epidemic trend based on Bayesian structured time series model.BMC Public Health. 2025 Apr 8;25(1):1312. doi: 10.1186/s12889-025-22305-2. BMC Public Health. 2025. PMID: 40197270 Free PMC article.
-
Estimating the Effects of the COVID-19 Outbreak on the Reductions in Tuberculosis Cases and the Epidemiological Trends in China: A Causal Impact Analysis.Infect Drug Resist. 2021 Nov 6;14:4641-4655. doi: 10.2147/IDR.S337473. eCollection 2021. Infect Drug Resist. 2021. PMID: 34785913 Free PMC article.
-
Interruption time series analysis using autoregressive integrated moving average model: evaluating the impact of COVID-19 on the epidemic trend of gonorrhea in China.BMC Public Health. 2023 Oct 23;23(1):2073. doi: 10.1186/s12889-023-16953-5. BMC Public Health. 2023. PMID: 37872621 Free PMC article.
-
Assessing the impact of non-pharmaceutical interventions against COVID-19 on 64 notifiable infectious diseases in Australia: A Bayesian Structural Time Series model.J Infect Public Health. 2025 Mar;18(3):102679. doi: 10.1016/j.jiph.2025.102679. Epub 2025 Jan 27. J Infect Public Health. 2025. PMID: 39879910
-
Evaluating the impact of COVID-19 outbreak on hepatitis B and forecasting the epidemiological trend in mainland China: a causal analysis.BMC Public Health. 2024 Jan 2;24(1):47. doi: 10.1186/s12889-023-17587-3. BMC Public Health. 2024. PMID: 38166922 Free PMC article.
References
-
- GBD 2021 Demographics Collaborators Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:1989–2056. 10.1016/S0140-6736(24)00476-8 - DOI - PMC - PubMed
-
- GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Antimicrobial Resistance C Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024;24:974–1002. 10.1016/S1473-3099(24)00176-2 - DOI - PMC - PubMed
-
- World Health Organization. Global tuberculosis report 2023. Geneva, Switzerland: World Health Organization; 2023. Available: https://www.who.int/publications/i/item/9789240083851. Accessed: 17 August 2024.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical